Clarius Group, LLC Bristol Myers Squibb CO Transaction History

Clarius Group, LLC

$1.39 Billion
Q2 2024

A detailed history of Clarius Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clarius Group, LLC holds 16,235 shares of BMY stock, worth $826,686. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,235

Previous 8,174 98.62%

Holding current value

$826,686

Previous $443,000 52.14%

% of portfolio

0.05%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$40.25 - $52.99 $324,455 - $427,152	8,061 Added 98.62%	16,235 $674,000
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $225,074 - $255,190	-4,691 Reduced 36.46%	8,174 $443,000
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $159,644 - $190,500	-3,293 Reduced 20.38%	12,865 $660,000
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $364,764 - $407,863	-6,301 Reduced 28.06%	16,158 $937,000
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $58,422 - $64,868	917 Added 4.26%	22,459 $1.44 Million
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $63,607 - $72,145	-968 Reduced 4.3%	21,542 $1.49 Million
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $147,848 - $175,073	2,159 Added 10.61%	22,510 $1.97 Million
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $58 - $34,654	451 Added 2.27%	20,351 $1.45 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $58,894 - $64,863	811 Added 4.25%	19,900 $1.53 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $222,779 - $259,708	-4,154 Reduced 17.87%	19,089 $1.19 Million
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $10,058 - $11,782	-170 Reduced 0.73%	23,243 $1.38 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $24,640 - $26,833	398 Added 1.73%	23,413 $1.56 Million
Q1 2021 Apr 27, 2021	BUY	$59.34 - $66.74 $129,064 - $145,159	2,175 Added 10.44%	23,015 $1.45 Million
Q4 2020 Jan 15, 2021	BUY	$57.74 - $65.43 $105,202 - $119,213	1,822 Added 9.58%	20,840 $1.29 Million
Q3 2020 Oct 09, 2020	SELL	$57.43 - $63.64 $21,249 - $23,546	-370 Reduced 1.91%	19,018 $1.15 Million
Q2 2020 Jul 08, 2020	BUY	$54.82 - $64.09 $128,388 - $150,098	2,342 Added 13.74%	19,388 $1.14 Million
Q1 2020 Apr 24, 2020	BUY	$46.4 - $67.43 $76,003 - $110,450	1,638 Added 10.63%	17,046 $950,000
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $272,967 - $356,061	5,547 Added 56.25%	15,408 $1.03 Million
Q3 2019 Oct 23, 2019	BUY	$42.77 - $50.71 $81,990 - $97,211	1,917 Added 24.13%	9,861 $500,000
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $34,491 - $38,139	773 Added 10.78%	7,944 $360,000
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $149,347 - $178,078	3,310 Added 85.73%	7,171 $342,000
Q4 2018 Feb 11, 2019	BUY	$48.76 - $63.23 $8,679 - $11,254	178 Added 4.83%	3,861 $201,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $203,264 - $229,266	3,683 New	3,683 $229,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Bristol Myers Squibb CO Transaction History